Stacey M Bagby Selected Research

Irinotecan (Camptosar)

10/2022	ATM kinase inhibitor AZD0156 in combination with irinotecan and 5-fluorouracil in preclinical models of colorectal cancer.
1/2021	WEE1 Inhibition in Combination With Targeted Agents and Standard Chemotherapy in Preclinical Models of Pancreatic Ductal Adenocarcinoma.
12/2017	The novel ATM inhibitor (AZ31) enhances antitumor activity in patient derived xenografts that are resistant to irinotecan monotherapy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Stacey M Bagby Research Topics

Disease

30	Neoplasms (Cancer) 01/2024 - 01/2014
10	Colorectal Neoplasms (Colorectal Cancer) 03/2024 - 01/2014
7	Melanoma (Melanoma, Malignant) 10/2021 - 01/2017
5	Triple Negative Breast Neoplasms 01/2024 - 11/2019
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2024 - 01/2018
2	Adenocarcinoma 01/2021 - 01/2018
2	Aneuploidy (Aneuploid) 11/2019 - 10/2018
1	Inflammation (Inflammations) 01/2023
1	T-Cell Lymphoma (Lymphoma, T Cell) 01/2022
1	Hepatocellular Carcinoma (Hepatoma) 01/2022
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Adrenocortical Carcinoma 01/2020
1	Neoplasm Metastasis (Metastasis) 01/2018
1	Polyploidy 01/2018

Drug/Important Bio-Agent (IBA)

6	Phosphotransferases (Kinase)IBA 10/2022 - 01/2014
5	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2020
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 10/2021 - 01/2014
3	RNA (Ribonucleic Acid)IBA 03/2024 - 01/2018
3	Irinotecan (Camptosar)FDA LinkGeneric 10/2022 - 12/2017
3	Proteins (Proteins, Gene)FDA Link 01/2018 - 01/2017
2	Gemcitabine FDA Link 01/2024 - 10/2020
2	Histone Deacetylase InhibitorsIBA 01/2024 - 01/2022
2	CytokinesIBA 01/2023 - 01/2021
2	Histones (Histone)IBA 01/2022 - 10/2019
2	Granzymes (Granzyme)IBA 01/2022 - 01/2020
2	Protein Isoforms (Isoforms)IBA 01/2022 - 01/2018
2	cabozantinibIBA 01/2022 - 10/2018
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 10/2021
2	adavosertibIBA 01/2021 - 03/2020
2	Capecitabine (Xeloda)FDA Link 01/2021 - 03/2020
2	RX-5902IBA 11/2020 - 11/2019
2	CateninsIBA 11/2020 - 11/2019
2	Aurora Kinase AIBA 01/2020 - 01/2015
2	MLN 8237IBA 01/2020 - 08/2016
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2024
1	ETC-159IBA 01/2024
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2024
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2024
1	Dinoprostone (PGE2)FDA Link 01/2023
1	Interleukin-2 (IL2)IBA 01/2023
1	Fluorouracil (Carac)FDA LinkGeneric 10/2022
1	AZD0156IBA 10/2022
1	Topoisomerase I InhibitorsIBA 10/2022
1	NivolumabIBA 01/2022
1	Histone Deacetylases (Histone Deacetylase)IBA 01/2022
1	HLA-DR Antigens (HLA-DR)IBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 01/2022
1	LigandsIBA 01/2022
1	palbociclibIBA 10/2021
1	trametinibIBA 10/2021
1	Hormones (Hormone)IBA 03/2020
1	pembrolizumabIBA 01/2020
1	sapanisertibIBA 01/2020
1	Genetic Markers (Genetic Marker)IBA 01/2020
1	S63845IBA 01/2020
1	navitoclaxIBA 01/2020
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2020
1	c-Mer Tyrosine KinaseIBA 01/2019
1	UNC2025IBA 01/2019
1	VemurafenibIBA 01/2019
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2019
1	SBI-0206965IBA 10/2018
1	Chloroquine (Aralen)FDA LinkGeneric 10/2018
1	ENMD 2076IBA 10/2018
1	tyrosine receptor (receptor, tyrosine)IBA 10/2018
1	regorafenibIBA 10/2018
1	Adenosine Triphosphate (ATP)IBA 01/2018
1	AldosteroneIBA 01/2018
1	4- ((9- cyclopentyl- 7,7- difluoro- 5- methyl- 6- oxo- 6,7,8,9- tetrahydro- 5H- pyrimido(4,5- b)(1,4)diazepin- 2- yl)amino)- 2- fluoro- 5- methoxy- N- (1- methylpiperidin- 4- yl)benzamideIBA 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Enterotoxin ReceptorsIBA 01/2018
1	Immunoconjugates (Immunoconjugate)IBA 01/2018
1	indusatumabIBA 01/2018
1	entrectinibIBA 01/2018
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 01/2017
1	pevonedistatIBA 01/2017
1	TAK 733IBA 10/2015
1	Drug CombinationsIBA 01/2015
1	mirdametinibIBA 01/2014

Therapy/Procedure

10	Therapeutics 10/2021 - 01/2015
4	Immunotherapy 12/2022 - 01/2020
1	Precision Medicine 12/2022
1	Salvage Therapy 10/2021
1	Drug Therapy (Chemotherapy) 01/2021
1	Molecular Targeted Therapy 01/2020